DeepMed Research

Northwestern University Human Resources

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1851-01-28

Employees: 5K

Market Cap: -

Website: https://www.venturecat.northwestern.edu

Clinical Trials

Teaching Skin Self -Examination to Melanoma Patients and Their Skin Check Partners

Not Applicable

Completed

Conditions: Melanoma

Interventions: Behavioral: Skin Self- examination structured training

First Posted Date: 2016-08-03

Last Posted Date: 2021-03-11

Lead Sponsor: Northwestern University

Target Recruit Count: 682

Registration Number: NCT02854657

Locations: 🇺🇸
June K Robinson, Chicago, Illinois, United States

Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma

Phase 2

Recruiting

Conditions: Anaplastic (Malignant) Meningioma
Recurrent Meningioma
Atypical Meningioma
Grade II Meningioma
Grade III Meningioma
Supratentorial Meningioma

Interventions: Biological: Bevacizumab
Procedure: Electric Field Therapy
Device: NovoTTF-200A Device
Procedure: Quality-of-Life Assessment

First Posted Date: 2016-07-28

Last Posted Date: 2024-12-10

Lead Sponsor: Northwestern University

Target Recruit Count: 27

Registration Number: NCT02847559

Locations: 🇺🇸
Vidant Medical Center, East Caroling University, Greenville, North Carolina, United States
🇺🇸
John Wayne Cancer Center at Providence St. John's Health Center, Santa Monica, California, United States
🇺🇸
Miami Cancer Institute, Miami, Florida, United States

and more 5 locations

Online Peer Networked Collaborative Learning for Managing Depressive Symptoms

Not Applicable

Completed

Conditions: Depression

Interventions: Behavioral: iCBT for late life depression

First Posted Date: 2016-07-22

Last Posted Date: 2018-10-29

Lead Sponsor: Northwestern University

Target Recruit Count: 47

Registration Number: NCT02841787

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States

Nivolumab and Yttrium Y 90 Glass Microspheres in Treating Patients With Advanced Liver Cancer

Phase 1

Completed

Conditions: Stage IVB Hepatocellular Carcinoma
Stage IIIB Hepatocellular Carcinoma
Stage IIIA Hepatocellular Carcinoma
Stage IIIC Hepatocellular Carcinoma
Stage IVA Hepatocellular Carcinoma

Interventions: Other: Laboratory Biomarker Analysis
Biological: Nivolumab
Radiation: Yttrium Y 90 Glass Microspheres

First Posted Date: 2016-07-19

Last Posted Date: 2022-01-25

Lead Sponsor: Northwestern University

Target Recruit Count: 27

Registration Number: NCT02837029

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States

Sacral Neuromodulation and the Microbiome

Completed

Conditions: Urgency Urinary Incontinence

Interventions: Device: InterStim Therapy

First Posted Date: 2016-07-14

Last Posted Date: 2023-11-18

Lead Sponsor: Northwestern University

Target Recruit Count: 50

Registration Number: NCT02833402

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States

Pain Perception: Lidocaine Rate/Temp/Buffer

Not Applicable

Active, not recruiting

Conditions: Pain

Interventions: Procedure: Buffered Injection
Procedure: Rapid, Room Temperature Injection
Procedure: Non-Buffered Injection
Procedure: Slow, Room Temperature Injection
Procedure: Slow, Warm Temperature Injection
Procedure: Rapid, Warm Temperature Injection
Drug: Lidocaine
Drug: Buffer

First Posted Date: 2016-07-06

Last Posted Date: 2024-03-15

Lead Sponsor: Northwestern University

Target Recruit Count: 26

Registration Number: NCT02823002

Locations: 🇺🇸
Northwestern University Department of Dermatology, Chicago, Illinois, United States

Project FACTS (Fidelity Accuracy: Comparing Three Strategies)

Not Applicable

Completed

Conditions: Assess Fidelity to Cognitive-behavioral Therapy for Youth

Interventions: Behavioral: Behavioral Rehearsal
Behavioral: Self-report
Behavioral: Chart-Stimulated Recall

First Posted Date: 2016-07-01

Last Posted Date: 2023-04-21

Lead Sponsor: Northwestern University

Target Recruit Count: 126

Registration Number: NCT02820623

A Universal Medication Schedule to Promote Adherence to Complex Drug Regimens

Not Applicable

Completed

Conditions: Adherence

Interventions: Behavioral: EHR + (Text or Portal)

First Posted Date: 2016-07-01

Last Posted Date: 2022-02-01

Lead Sponsor: Northwestern University

Target Recruit Count: 677

Registration Number: NCT02820753

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States

Nivolumab and Dasatinib in Treating Patients With Relapsed or Refractory Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Phase 1

Terminated

Conditions: Recurrent Adult Acute Lymphoblastic Leukemia
Refractory Adult Acute Lymphoblastic Leukemia
B Acute Lymphoblastic Leukemia With t(9;22)(q34;q11.2); BCR-ABL1
Recurrent Childhood Acute Lymphoblastic Leukemia
Refractory Childhood Acute Lymphoblastic Leukemia

Interventions: Drug: Dasatinib
Other: Laboratory Biomarker Analysis
Biological: Nivolumab
Other: Pharmacological Study

First Posted Date: 2016-06-30

Last Posted Date: 2020-02-11

Lead Sponsor: Northwestern University

Target Recruit Count: 1

Registration Number: NCT02819804

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States

Designing a Programming Language for Patient-Oriented Prescriptions

Completed

Conditions: Programming Languages
Patients

First Posted Date: 2016-06-30

Last Posted Date: 2019-02-12

Lead Sponsor: Northwestern University

Target Recruit Count: 56

Registration Number: NCT02820168

Locations: 🇺🇸
Northwestern Medicine Clinics, Chicago, Illinois, United States
🇺🇸
Northwestern Memorial Hospital, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy